UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 238

Sortiert nach

Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS

Neurology, 2002-09, Vol.59 (6), p.909

2002

Volltextzugriff (PDF)

A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis

Multiple sclerosis, 2002-10, Vol.8 (5), p.441-445

2002

Volltextzugriff (PDF)

Psychological stress and the subsequent appearance of new brain MRI lesions in MS

Neurology, 2000-07, Vol.55 (1), p.55

2000

Volltextzugriff (PDF)

Drugs used to treat spasticity

Drugs (New York, N.Y.), 2000-03, Vol.59 (3), p.487-495

2000

Volltextzugriff (PDF)

A serial study of new MS lesions and the white matter from which they arise

Neurology, 1998-12, Vol.51 (6), p.1689

1998

Volltextzugriff (PDF)

Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis

Annals of neurology, 1995-01, Vol.37 (1), p.30-40

1995

Volltextzugriff (PDF)

MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy

Journal of neurology, neurosurgery and psychiatry, 2003-07, Vol.74 (7), p.950-952

2003

Volltextzugriff (PDF)

Side effect profile of interferon beta-1b in MS: results of an open label trial

Neurology, 1996-02, Vol.46 (2), p.552

1996

Volltextzugriff (PDF)

A phase II study of i.v. methylprednisolone in secondary-progressive multiple sclerosis

Neurology, 1998-07, Vol.51 (1), p.239

1998

Volltextzugriff (PDF)

Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI)

Neurology, 1995-04, Vol.45 (4), p.718

1995

Volltextzugriff (PDF)

Interferon β therapy for multiple sclerosis

The Lancet (British edition), 1998-11, Vol.352 (9139), p.1486-1487

Goodkin, Donald E

1998

Volltextzugriff (PDF)

Overview of azathioprine treatment in multiple sclerosis

The Lancet (British edition), 1991-10, Vol.338 (8774), p.1051-1055

1991

Volltextzugriff (PDF)

Telephone-Administered Cognitive-Behavioral Therapy for the Treatment of Depressive Symptoms in Multiple Sclerosis

Journal of consulting and clinical psychology, 2000-04, Vol.68 (2), p.356-361

2000

Volltextzugriff (PDF)

Low-dose oral methotrexate in chronic progressive multiple sclerosis: analyses of serial MRIs

Neurology, 1996-11, Vol.47 (5), p.1153

1996

Volltextzugriff (PDF)

A longitudinal study of ventricular volume in early relapsing-remitting multiple sclerosis

Multiple sclerosis, 2000-10, Vol.6 (5), p.332-337

2000

Volltextzugriff (PDF)

Glucocorticosteroid therapy for multiple sclerosis: A critical review

Journal of the neurological sciences, 1998-09, Vol.160 (1), p.16-25

1998

Volltextzugriff (PDF)

Identification of Beck Depression Inventory items related to multiple sclerosis

Journal of behavioral medicine, 1997-08, Vol.20 (4), p.407-414

1997

Volltextzugriff (PDF)

Interferon beta-1b

The Lancet (British edition), 1994-10, Vol.344 (8929), p.1057-1060

Goodkin, D.E.

1994

Volltextzugriff (PDF)

T2 relaxation time histograms in multiple sclerosis

Magnetic resonance imaging, 2002-12, Vol.20 (10), p.733-741

2002

Volltextzugriff (PDF)

A pilot study of MRI activity before and during interferon beta-1a therapy

Neurology, 1999-09, Vol.53 (4), p.874

1999

Volltextzugriff (PDF)

Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis

Neurology, 1999-10, Vol.53 (7), p.1397

1999

Volltextzugriff (PDF)

The Psychosocial Impact of Multiple Sclerosis: Exploring the Patient's Perspective

Health psychology, 1999-07, Vol.18 (4), p.376-382

1999

Volltextzugriff (PDF)

Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject

Annals of behavioral medicine, 2001, Vol.23 (2), p.125-132

2001

Volltextzugriff (PDF)

Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis

Archives of neurology (Chicago), 1997-05, Vol.54 (5), p.531

1997

Volltextzugriff (PDF)

Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis

Multiple sclerosis, 1999-06, Vol.5 (3), p.192-197

1999

Volltextzugriff (PDF)

1 – 25 von 238

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(213)
Mit Volltextzugriff
(167)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Neurology
(31)
Multiple Sclerosis
(30)
Archives Of Neurology
(19)
Annals Of Neurology
(14)
Neurosurgery
(10)
Kidney International
(9)
Nephrology, Dialysis, Transplantation
(7)
The Lancet
(7)
Epilepsia
(6)
Journal Of Neuroimmunology
(6)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS

A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis

Psychological stress and the subsequent appearance of new brain MRI lesions in MS

Drugs used to treat spasticity

A serial study of new MS lesions and the white matter from which they arise

Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis

MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy

Side effect profile of interferon beta-1b in MS: results of an open label trial

A phase II study of i.v. methylprednisolone in secondary-progressive multiple sclerosis

Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI)

Interferon β therapy for multiple sclerosis

Overview of azathioprine treatment in multiple sclerosis

Telephone-Administered Cognitive-Behavioral Therapy for the Treatment of Depressive Symptoms in Multiple Sclerosis

Low-dose oral methotrexate in chronic progressive multiple sclerosis: analyses of serial MRIs

A longitudinal study of ventricular volume in early relapsing-remitting multiple sclerosis

Glucocorticosteroid therapy for multiple sclerosis: A critical review

Identification of Beck Depression Inventory items related to multiple sclerosis

Interferon beta-1b

T2 relaxation time histograms in multiple sclerosis

A pilot study of MRI activity before and during interferon beta-1a therapy

Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis

The Psychosocial Impact of Multiple Sclerosis: Exploring the Patient's Perspective

Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject

Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis

Treatment adherence and patient retention in the first year of a Phase-III clinical trial for the treatment of multiple sclerosis

Suchergebnisse filtern